Skip to main content
Benaroya Research Institute

Main navigation

  • About BRI
    • Leadership
    • Faculty
    • Administrative Leaders
    • Together We Discover
    • Contact Us
  • Our Research
    • Centers of Discovery
      • Fundamental Immunology
      • Translational Immunology
      • Interventional Immunology
      • Systems Immunology
        • Bioinformatics at BRI
    • Labs
    • Biorepositories
      • Be a Part of BRI Research
    • Clinical Research
      • Allergies & Asthma Clinical Research
    • Core Labs
      • Cell And Tissue Analysis Group
      • Genomics Core
      • Human Immunophenotyping Core
      • Protein and Tetramer Core
        • Protein & Tetramer Core Ordering
    • Immune Tolerance Network
    • Scientific Publications
    • Scientific Meetings at BRI
      • Asthma Research Symposium
      • BRI Immunology Symposium: New Horizons in Immunity and Disease
      • Cross Autoimmunity Prevention Symposium
  • Collaborations with BRI
    • Opportunities for Collaboration
    • Technology Available for Licensing
  • News
    • Press Releases
  • Support our Research
    • Donate Now
    • BRI Events
      • BRI Open House
      • Immunology to Change Lives

Utility Menu

  • Immunology Learning Center
  • Autoimmune Life Blog
  • Careers
  • Clinical Research at VMMC
  • Donate
  • Search
    • Jan 2020

      Escherichiacoli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn's Disease.

      Cell Mol Gastroenterol Hepatol
      Uchida AM, Boden EK, James EA, Shows DM, Konecny AJ, Lord JD
    • Jan 2020

      Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.

      Arthritis Rheumatol
      Galindo-Feria AS, Albrecht I, Fernandes-Cerqueira C, Notarnicola A, James EA, Herrath J, Dastmalchi M, Sandalova T, Rönnblom L, Jakobsson PJ, Fathi M, Achour A, Grunewald J, Malmström V, Lundberg IE
    • Dec 2019

      A composite immune signature parallels disease progression across T1D subjects.

      JCI Insight
      Speake C, Skinner SO, Berel D, Whalen E, Dufort MJ, Young WC, Odegard JM, Pesenacker AM, Gorus FK, James EA, Levings MK, Linsley PS, Akirav EM, Pugliese A, Hessner MJ, Nepom GT, Gottardo R, Long SA
    • Nov 2019

      Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.

      Allergy
      Rudulier CD, Tonti E, James EA, Kwok WW, Larché M
    • Oct 2019

      Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain.

      Cancer Immunol Res
      Longino NV, Yang J, Iyer JG, Ibrani D, Chow IT, Laing KJ, Campbell VL, Paulson KG, Kulikauskas RM, Church CD, James EA, Nghiem P, Kwok WW, Koelle DM
    • Sep 2019

      Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells.

      J Immunol
      Meckiff BJ, Ladell K, McLaren JE, Ryan GB, Leese AM, James EA, Price DA, Long HM
    • Aug 2019

      Discriminative T cell recognition of cross-reactive islet-antigens is associated with HLA-DQ8 transdimer-mediated autoimmune diabetes.

      Sci Adv
      Chow IT, Gates TJ, Papadopoulos GK, Moustakas AK, Kolawole EM, Notturno RJ, McGinty JW, Torres-Chinn N, James EA, Greenbaum CJ, Nepom GT, Kwok WW
    • Jul 2019

      Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.

      Diabetes
      Ahmed S, Cerosaletti K, James EA, Long SA, Mannering SI, Speake C, Nakayama M, Tree T, Roep BO, Herold KC, Brusko TM
    • Apr 2019

      Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis.

      Arthritis Rheumatol
      Rims C, Uchtenhagen H, Kaplan MJ, Carmona-Rivera C, Carlucci P, Mikecz K, Markovics A, Carlin J, Buckner JH, James EA
    • Jan 2019

      Analysis of pancreatic beta cell specific CD4+ T cells reveals a predominance of proinsulin specific cells.

      Cell Immunol
      Blahnik G, Uchtenhagen H, Chow IT, Speake C, Greenbaum CJ, Kwok WW, James EA
    • Dec 2018

      DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.

      J Immunol
      James EA, Gillette L, Durinovic-Belló I, Speake C, Bondinas GP, Moustakas AK, Greenbaum CJ, Papadopoulos GK, Kwok WW
    • Dec 2018

      A Novel Approach of Identifying Immunodominant Self and Viral Antigen Cross-Reactive T Cells and Defining the Epitopes They Recognize.

      Front Immunol
      Yang J, Jing L, James EA, Gebe JA, Koelle DM, Kwok WW
    • Nov 2018

      Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes.

      Diabetes
      Buitinga M, Callebaut A, Marques Câmara Sodré F, Crèvecoeur I, Blahnik-Fagan G, Yang ML, Bugliani M, Arribas-Layton D, Marré M, Cook DP, Waelkens E, Mallone R, Piganelli JD, Marchetti P, Mamula MJ, Derua R, James EA, Mathieu C, Overbergh L
    • Oct 2018

      Peanut-specific T cell responses in patients with different clinical reactivity.

      PLoS One
      Birrueta G, Tripple V, Pham J, Manohar M, James EA, Kwok WW, Nadeau KC, Sette A, Peters B, Schulten V
    • Sep 2018

      Regulatory CD4+ T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein B.

      Circulation
      Kimura T, Kobiyama K, Winkels H, Tse K, Miller J, Vassallo M, Wolf D, Ryden C, Orecchioni M, Dileepan T, Jenkins MK, James EA, Kwok WW, Hanna DB, Kaplan RC, Strickler HD, Durkin HG, Kassaye SG, Karim R, Tien PC, Landay AL, Gange SJ, Sidney J, Sette A, Ley K

Pagination

First page « First Previous page ‹ Previous … Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 … Next page Next › Last page Last »
Benaroya Research Institute

1201 Ninth Avenue
Seattle, WA 98101-2795
(206) 342-6500

facebook Bluesky instagram linkedin youtube threads
Resources
  • Support our Research
  • Subscribe to News
  • Careers
  • Contact Us
  • Research Conflicts of Interest
  • Research Security Program
  • Terms of Use
  • Research Requirements
If you would like to contact us regarding the accessibility of our website, please contact us at 206-342-6500 or email communications@benaroyaresearch.org.
© 2025 Benaroya Research Institute, a 501(c)(3) nonprofit organization
Close Close